Wise Practice of Chinese Hemodialysis (WISHES)

Sun Yat-sen University

Status: Enrolling

Conditions: Haemolyses and Related Conditions

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT03001921

WISHES

Details and patient eligibility

About

The investigators are registering all HD patients at recruited hospitals and developing a HD database in China. Patients will be follow-up every 3 months, and both baseline and follow-up information will be entered into the registration system. The patient survival, technical survival, patency rate of access, quality of life and residual renal function for HD patients will be compared using the HD database.

Full description

The investigators are registering all end stage renal disease (ESRD) patients receiving hemodialysis (HD) treatment, and developing a HD database in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and education), clinical characteristics (including systolic blood pressure, diastolic blood pressure, primary cause of ESRD, and lab measurements of serum, urine, and access patency), complications, drug information and scores of quality of life at the baseline will be collected. Patients will be follow-up every 3 month, the demographic and clinical characteristics, complications and drug information of patients will be collected at each visit. The investigators also record the outcome at each visit, such as mortality (including all-cause mortality and cardiovascular disease mortality), technical survival, kidney transplantation, transfer to peritoneal dialysis, hospitalization, access failure，etc. The patient survival, technical survival, patency rate of access, quality of life and residual renal function for HD patients will be compared using the HD database.

Enrollment: 30,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

End stage renal disease patients receiving hemodialysis treatment.

Exclusion criteria

No

Trial design

30,000 participants in 1 patient group

Hemodialysis patients

Description:

End stage renal disease patients receiving hemodialysis treatment

Treatment:

Other: No intervention